from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0468/fadB2

LFCtreatmentdescriptionclass of inhibitor

-0.111

Amikacinug/mL Amikacintranslation

0.571

Cap5-10ug/mL Capreomycintranslation

0.158

Rox10-50 ug/mL Roxithromycintranslation

0.124

SM2-5 ug/mL Streptomycintranslation

-0.346

Tet5-10 ug/mL Tetracyclinetranslation

-0.216

Rif0.2-5ug/mL Rifampicintranscription

0.051

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.022

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.872

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.194

CPZ10-50 ug/mL Chlorpromazinerespiration

2.398

Clofazimine10-13 ug/mL Clofaziminerespiration

0.189

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.801

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.432

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.713

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.641

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.186

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.365

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.384

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.062

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.846

KCN5-20 ug/mL Potassium cyaniderespiration

-0.383

NaN30.2-2 mM Sodium aziderespiration

-0.502

Nigericin50 uM Nigericinrespiration

-0.086

TRC10-150 ug/mL Triclosanrespiration

0.311

TRZ10-25 ug/mL Thioridazinerespiration

-0.319

Valinomycin0.5-10 uM Valinomycinrespiration

-1.184

ZnSO42 mM ZnSO4respiration

-0.130

menadione6-10 ug/mL Menadionerespiration

1.299

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.046

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.145

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.465

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.012

NRP_1Non-replicating persistence stage 1dosRassociated

-0.399

Amp0.2mg/mL AmpicillincellWall

-0.338

Cephalexin20-100 ug/mL CephalexincellWall

0.391

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.909

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.113

EMB10-20 ug/mL EthambutolcellWall

-0.232

Eta12-40 ug/mL EthionamidecellWall

-0.557

INH0.2-0.4 ug/mL IsoniazidcellWall

0.249

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.113

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.201

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.308

BZA0.12 mg/mL BenzamidearomaticAmides

-0.352

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.685

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.274

H2O24 mM hydrogen peroxideDNAdamaging

-0.061

Levo10 ug/mL LevofloxacinDNAdamaging

0.536

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.772

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.347

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.421

UVUV-irradiationDNAdamaging

0.644

ARP41-4 ug/mL Antitubercular compound ARP4?

0.548

Antimycin12.5-50 ug/mL Antimycin A?

-0.414

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.396

PA_110-50 ug/mL Antitubercular compound PA-1?

0.363

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.492

PA8240.2-2 ug/mL PA-824?

1.404

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.132

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.523

Verapamil50 uM Verapamil?

-0.515

mercaptoethanol2 mM 2-Mercaptoethanol?

0.102

methoxatin10-20 ug/mL Methoxatin?